M&A / Deals Asahi Kasei acquires German company Aicuris Pharmaceutical TechnologyAsahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company.M&A / DealsRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaceutical Technology Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company. M&A / DealsRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Trump executive order lifts psychedelics biotechsNext: Italy leads the way on child genetic disease diagnosis Related Stories M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026 M&A / Deals GSK ends dementia alliance with Alector after setbacks pharminent July 9, 2026 M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals pharminent July 8, 2026
